Dexcom Appoints Glenn Boehnlein to Board of Directors Dexcom has appointed Glenn Boehnlein to its Board of Directors, effective September 10, 2026. The appointment adds more than 20 years of medical technology experience and healthcare executive leadership to Dexcom’s board as the company advances its long-term growth strategy. Read related news - https://cxoinsiders.com/fortive-appoints-susan-main-to-board-of-directors/ Read full news - https://cxoinsiders.com/dexcom-appoints-glenn-boehnlein-to-board-of-directors/